David B. Jones, Senior Vice President, General Counsel, and Chief Compliance Officer at Innospec Inc., has reported a transaction involving phantom stock. This event is significant as it highlights his ongoing commitment to the company and its executive compensation strategies.
Background
Innospec Inc. is a company in the chemicals and allied products sector, specifically classified under the SIC code 2800. The firm is incorporated in Delaware and has been active in various chemical applications and services. Recent filings indicate that Jones has been involved in multiple transactions, reflecting his role within the company.
What the Filing Says
According to the recent filing dated October 5, 2026, Jones reported acquiring 3,188 shares of phantom stock on October 1, 2026. Each share of phantom stock is equivalent to one share of Innospec's common stock. The filing states, "Award will vest according to the following schedule: 25% on February 1, 2027; 25% on October 1, 2027; and 50% on October 1, 2028." This indicates a structured approach to executive compensation.
Impact
This transaction may affect Innospec's executive compensation landscape and how the company attracts and retains top talent. The chemicals industry, as a whole, may observe similar trends as firms adjust their compensation strategies to remain competitive.
What's Next
The filing does not say what happens next.